Significant hypertrophy regression with indapamide sustained release 1.5 mg.
D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy*; D007190:Indapamide / Q000008:administration & dosage* / Q000627:therapeutic use*; D012044:Regression Analysis
D000959:Antihypertensive Agents; D003692:Delayed-Action Preparations; D007190:Indapamide